Hardeep Singh Tuli Selected Research

Hardeep Singh Tuli Research Topics

Disease

32	Neoplasms (Cancer) 09/2022 - 12/2015
12	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2015
6	Inflammation (Inflammations) 09/2022 - 01/2018
5	Carcinogenesis 09/2022 - 06/2015
3	Breast Neoplasms (Breast Cancer) 09/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 09/2022 - 08/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
3	COVID-19 01/2021 - 01/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 10/2016
2	Lymphoma (Lymphomas) 09/2022 - 08/2018
2	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 04/2020
2	Infections 01/2022 - 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022
1	Multiple Myeloma 09/2022
1	Insulin Resistance 03/2022
1	Type 2 Diabetes Mellitus (MODY) 03/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Bacterial Pneumonia 01/2022
1	Dysbiosis 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Malaria 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2020
1	Colonic Neoplasms (Colon Cancer) 04/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Uterine Cervical Dysplasia 01/2020

Drug/Important Bio-Agent (IBA)

7	AntioxidantsIBA 01/2022 - 06/2015
7	PhytochemicalsIBA 01/2022 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 09/2022 - 06/2015
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
4	FlavonoidsIBA 01/2022 - 02/2018
3	Biological ProductsIBA 06/2021 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2018
3	QuercetinIBA 01/2019 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 09/2022 - 04/2020
2	Untranslated RNA (Noncoding RNA)IBA 09/2022 - 09/2020
2	PolyphenolsIBA 03/2022 - 03/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 01/2017
2	VaccinesIBA 01/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 11/2019
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2019
2	fisetinIBA 01/2019 - 02/2018
1	silidianinIBA 03/2022
1	Synthetic DrugsIBA 03/2022
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 03/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Tyrosine (L-Tyrosine)FDA Link 03/2022
1	lefamulinIBA 01/2022
1	galanginIBA 01/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2022
1	PleuromutilinsIBA 01/2022
1	Gallic AcidIBA 01/2022
1	Propolis (Bee Bread)IBA 01/2022
1	MacrolidesIBA 01/2022
1	CateninsIBA 01/2022
1	betulinIBA 12/2021
1	Chalcone (Benzalacetophenone)IBA 12/2021
1	buteinIBA 12/2021
1	Emodin (Archin)IBA 06/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Cyclin D1IBA 01/2021
1	Caspase 9IBA 01/2021
1	Caspase 8 (Caspase-8)IBA 01/2021
1	Silybin (Lagosa)IBA 01/2021
1	Cyclin AIBA 01/2021
1	favipiravirIBA 01/2021
1	kurarinoneIBA 01/2021
1	VimentinIBA 01/2021
1	deguelinIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	PrebioticsIBA 01/2021
1	Cytostatic AgentsIBA 01/2021
1	curdlanIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	baicaleinIBA 10/2020
1	Long Noncoding RNAIBA 09/2020
1	garcinolIBA 04/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	TabletsIBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	LactoferrinIBA 01/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2019
1	Protein Kinases (Protein Kinase)IBA 11/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2016
4	Drug Therapy (Chemotherapy) 06/2021 - 02/2018
2	Immunotherapy 06/2021 - 01/2021
1	Radiotherapy 01/2021
1	Complementary Therapies (Alternative Medicine) 01/2020